Biosynthesis of the third and fifth complement components by isolated human lung cellsROTHMAN, B. L; MERROW, M; BAMBA, M et al.The American review of respiratory disease. 1989, Vol 139, Num 1, pp 212-220, issn 0003-0805, 9 p.Article

MALADIE DES MEMBRANES HYALINES: ETUDE EN IMMUNO-FLUORESCENCE DU TISSU PULMONAIRE; NOTE PRELIMINAIREBENATRE A; LAUGIER J; FETISSOV M et al.1973; NOUV. PRESSE MED.; FR.; DA. 1973; VOL. 2; NO 8; PP. 497-498; BIBL. 3 REF.Serial Issue

Synthesis of soluble C3 and C9 neoepitopes by human alveolar macrophages in vitroPETTERSON, H. B; JOHNSON, E; MOLLNES, T. E et al.Scandinavian journal of immunology (Print). 1988, Vol 28, Num 4, pp 431-434, issn 0300-9475Article

Effect of interleukin-4 on the synthesis of the third component of complement by pulmonary epithelial cellsCHRISTIAN-RITTER, K. K; HILL, L. D; HOIE, E. B et al.The American journal of pathology. 1994, Vol 144, Num 1, pp 171-176, issn 0002-9440Article

IL-22 suppresses IFN-γ―mediated lung inflammation in asthmatic patientsPENNINO, Davide; BHAVSAR, Pankaj K; EYERICH, Kilian et al.Journal of allergy and clinical immunology. 2013, Vol 131, Num 2, pp 562-570, issn 0091-6749, 9 p.Article

IL-22 attenuates IL-25 production by lung epithelial cells and inhibits antigen-induced eosinophilic airway inflammationTAKAHASHI, Kentaro; HIROSE, Koichi; NAKAJIMA, Hiroshi et al.Journal of allergy and clinical immunology. 2011, Vol 128, Num 5, pp 1067-1076, issn 0091-6749, 10 p.Article

COMPLEMENT (C3)-ACTIVATED PHAGOCYTOSIS BY LUNG MACROPHAGES.SHURIN SB; STOSSEL TP.1978; J. IMMUNOL.; U.S.A.; DA. 1978; VOL. 120; NO 4; PP. 1305-1312; BIBL. 30 REF.Article

IMMUNOHISTOLOGIC FINDINGS IN THE LUNG IN SYSTEMIC LUPUS ERYTHEMATOSUS.RODRIGUEZ ITURBE B; GARCIA R; RUBIO L et al.1977; ARCH. PATHOL. LAB. MED.; U.S.A.; DA. 1977; VOL. 101; NO 7; PP. 342-344; BIBL. 32 REF.Article

Systemic complement system depletion does not inhibit cellular accumulation in antihistamine pretreated allergic guinea pig lungREGAL, J. F; FRASER, D. G.International archives of allergy and immunology. 1996, Vol 109, Num 2, pp 150-160, issn 1018-2438Article

Complement and neutrophil activation during cardiopulmonary bypass : a study in the complement-deficient dog. DiscussionGILLINOV, A. M; REDMOND, J. M; WINKELSTEIN, J. A et al.GILLINOV, A. M; The Annals of thoracic surgery. 1994, Vol 57, Num 2, pp 345-352, issn 0003-4975Conference Paper

C1q and C3 in bronchoalveolar lavage fluid from patients with summer-type hypersensibility pneumonitisSODA, K; ANDO, M; SAKATA, T et al.Chest. 1988, Vol 93, Num 1, pp 76-80, issn 0012-3692, supplArticle

Innate immune defense against pneumococcal pneumonia requires pulmonary complement component C3KERR, Alison R; PATERSON, Gavin K; RIBOLDI-TUNNICLIFFE, Alan et al.Infection and immunity. 2005, Vol 73, Num 7, pp 4245-4252, issn 0019-9567, 8 p.Article

C3 as substrate for adhesion of Streptococcus pneumoniaeSMITH, B. L; HOSTETTER, M. K.The Journal of infectious diseases. 2000, Vol 182, Num 2, pp 497-508, issn 0022-1899Article

C3 synthesis by A549 alveolar epithelial cells is increased by interferon-γ and dexamethasoneHILL, L. D; SUN, L; LEUSCHEN, M. P et al.Immunology (Oxford). 1993, Vol 79, Num 2, pp 236-240, issn 0019-2805Article

Interleukin-4 augments production of the third complement component by the alveolar epithelial cell line A549KHIRWADKAR, K; ZILOW, G; OPPERMANN, M et al.International archives of allergy and immunology. 1993, Vol 100, Num 1, pp 35-41, issn 1018-2438Article

Complement Components (C3, C4) as Inflammatory Markers in AsthmaMOHAMMED ABDEL FATTAH; MOHAMMED EL BAZ; SHERIF, Ashraf et al.Indian journal of pediatrics. 2010, Vol 77, Num 7, pp 771-773, issn 0019-5456, 3 p.Article

IL-22 : A critical mediator in mucosal host defenseAUJLA, S. J; KOLLS, J. K.Journal of molecular medicine (Berlin. Print). 2009, Vol 87, Num 5, pp 451-454, issn 0946-2716, 4 p.Article

Polymorphisme du C3 du complément chez des patients atteints de bronchopneumopathie chronique obstructive en Tunisie = C3 complement polymorphism in patients suffering from obstructive chronic bronchopneumopathy in TunisiaLEBAN, N; HAJ KHELIL, A; DAIMI, H et al.Annales de biologie clinique (Paris). 2007, Vol 65, Num 3, pp 251-256, issn 0003-3898, 6 p.Article

Antiapoptotic Activity of Autocrine Interleukin-22 and Therapeutic Effects of lnterleukin-22-Small Interfering RNA on Human Lung Cancer XenograftsWEICI ZHANG; YONGYAN CHEN; HAIMING WEI et al.Clinical cancer research (Print). 2008, Vol 14, Num 20, pp 6432-6439, issn 1078-0432, 8 p.Article

FC AND C3B RECEPTORS ON PULMONARY ENDOTHELIAL CELLS: INDUCTION BY INJURYRYAN US; SCHULTZ DR; RYAN JW et al.1981; SCIENCE; ISSN 0036-8075; USA; DA. 1981; VOL. 214; NO 4520; PP. 557-558; BIBL. 16 REF.Article

METABOLISM OF THE LEUKOTRIENE C₃ IN THE GUINEA PIG. IDENTIFICATION OF METABOLITES FORMED BY LUNG, LIVER AND KIDNEYHAMMARSTROM S.1981; J. BIOL. CHEM.; ISSN 0021-9258; USA; DA. 1981; VOL. 256; NO 18; PP. 9573-9578; BIBL. 15 REF.Article

ANAPHYLATOXIN-MEDIATED CONTRACTION OF GUINEA PIG LUNG STRIPS: A NONHISTAMINE TISSUE RESPONSESTIMLER NP; BROCKLEHURST WE; BLOOR CM et al.1981; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1981; VOL. 126; NO 6; PP. 2258-2261; BIBL. 29 REF.Article

Welche Kältemittel in der Zukunft? = Which refrigerant in the future?DOÊRING, R.Die Kälte und Klimatechnik. 1990, Vol 43, Num 9, pp 472-482, issn 0343-2246, 6 p.Article

Th17 cytokines and mucosal immunityDUBIN, Patricia J; KOLLS, Jay K.Immunological reviews. 2008, Vol 226, pp 160-171, issn 0105-2896, 12 p.Article

IL-22, but Not IL-17, Dominant Environment in Cutaneous T-cell LymphomaMIYAGAKI, Tomomitsu; SUGAYA, Makoto; SUGA, Hiraku et al.Clinical cancer research (Print). 2011, Vol 17, Num 24, pp 7529-7538, issn 1078-0432, 10 p.Article